Topic: Taxotere
Peregrine Pharmaceuticals says bavituximab prompts response in breast cancer patientsPeregrine Pharmaceuticals Inc. said Wednesday its drug candidate bavituximab prompted an improvement in response rates in advanced breast cancer patients during a midstage clinical trial.The company said its experimental drug bavituximab, in combination ...